Avidity Partners Management LP 13D and 13G filings for Jasper Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 6:01 pm Sale | 2024-09-30 | 13G | Jasper Therapeutics, Inc. JSPR | Avidity Partners Management LP | 0 0.000% | -760,000 (Position Closed) | Filing |
| 2024-03-27 4:26 pm Purchase | 2024-03-18 | 13G | Jasper Therapeutics, Inc. JSPR | Avidity Partners Management LP | 760,000 5.100% | 760,000 (New Position) | Filing |